131 related articles for article (PubMed ID: 819452)
1. Determination of dihydroergotoxine alkaloids by gas-liquid chromatography.
Szepesi G; Gazdag M
J Chromatogr; 1976 Jul; 122():479-85. PubMed ID: 819452
[TBL] [Abstract][Full Text] [Related]
2. Separation of dihydroergotoxine (hydergine) into dihydroergocornine, dihydroergocryptine and dihydroergocristine by counter-current distribution.
Galeffi C; Delle Monache EM
J Chromatogr; 1974 Jan; 88(2):413-5. PubMed ID: 4205319
[No Abstract] [Full Text] [Related]
3. Dihydroergotoxine: separation and determination of four components by high-performance liquid chromatography.
Hartmann V; Rödiger M; Ableidinger W; Bethke H
J Pharm Sci; 1978 Jan; 67(1):98-103. PubMed ID: 412946
[TBL] [Abstract][Full Text] [Related]
4. Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary results.
Bicalho B; Giolo JM; Lilla S; De Nucci G
Biopharm Drug Dispos; 2008 Jan; 29(1):17-28. PubMed ID: 17941060
[TBL] [Abstract][Full Text] [Related]
5. [Separation of some multicomponent preparations by means of column chromatography. I. Separation of dihydroergotoxine (Hydergine) from p-aminobenzoyl-2-diethylamino-4-methylpentanone methanesulphonate (Panthesine)].
Margasiński Z; Danielak R; Rafalowska H; Nowakowska Z
Acta Pol Pharm; 1967; 24(3):301-5. PubMed ID: 4964297
[No Abstract] [Full Text] [Related]
6. Validated liquid chromatography-tandem mass spectrometry method for simultaneous determination of clopamide, reserpine and dihydroergotoxine: Application to pharmacokinetics in human plasma.
Sharaf El-Din MM; Nassar MW; Attia KA; Demellawy MA; Kaddah MM
J Pharm Biomed Anal; 2016 Jun; 125():236-44. PubMed ID: 27037980
[TBL] [Abstract][Full Text] [Related]
7. [Stability of liquid ergotalkaloid preparations as a function of the solvent polarity (author's transl)].
Hartmann V; Schnabel G; Ohlrich HJ
Arzneimittelforschung; 1977; 27(12):2276-83. PubMed ID: 414760
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic ergot vasospastic angiitis. A case report.
Kapoor OP
Vasc Surg; 1976; 10(1):58-60. PubMed ID: 822626
[TBL] [Abstract][Full Text] [Related]
9. On the hypertensive action of tolazoline and hydergine.
BENFEY BG; VARMA DR
Can J Biochem Physiol; 1963 Apr; 41():941-6. PubMed ID: 13967428
[No Abstract] [Full Text] [Related]
10. [USE OF THE ERGOT ALKALOID PREPARATION, HYDERGINE, IN SURGERY].
WATANUKI T; ISHIZUKA T; MOCHIZUKI N
Rinsho Geka; 1964 May; 19():694-9. PubMed ID: 14148895
[No Abstract] [Full Text] [Related]
11. The hydrogenated ergot alkaloids (hydergine); a hypotensive agent.
SCHULTZ FB
Am Pract Dig Treat; 1953 May; 4(5):330-6. PubMed ID: 13050917
[No Abstract] [Full Text] [Related]
12. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
Henriet M; Jacquy J; Noel G
Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
[No Abstract] [Full Text] [Related]
13. Hydrogenated ergot alkaloids (hydergine) in the treatment of geriatric postural dizziness.
ORMA EJ
Ann Med Intern Fenn; 1956; 45(1):39-44. PubMed ID: 13355071
[No Abstract] [Full Text] [Related]
14. Clinical evaluation of combined hydrogenated ergot alkaloids (hydergine) in arterial hypertension with special reference to their action in central manifestations.
TANDOWSKY RM
Circulation; 1954 Jan; 9(1):48-56. PubMed ID: 13116375
[No Abstract] [Full Text] [Related]
15. [EFFECT OF REDERGAM ON VASCULAR REACTIONS FOLLOWING THE STIMULATION OF THE SCIATIC NERVE].
VEDERNIKOV IuP
Farmakol Toksikol; 1964; 27():157-9. PubMed ID: 14193076
[No Abstract] [Full Text] [Related]
16. [CLINICAL EVLUATION OF HYDERGINE IN GERIATRIC THERAPY].
SOPRANA M; FRANZONI A
Minerva Med; 1965 Jun; 56():2220-6. PubMed ID: 14341447
[No Abstract] [Full Text] [Related]
17. [19 CASES OF SUDEK-KIENBOECK ACUTE ATROPHY TREATED WITH HYDERGINE].
RONCALLI-BENEDETTI L; SOAVE G
Minerva Chir; 1964 May; 19():363-6. PubMed ID: 14158733
[No Abstract] [Full Text] [Related]
18. [Clinical experiences with the vascular action of dihydroergocristine].
Tomasi AM; Baggioni GF; Pozzar C
Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
[No Abstract] [Full Text] [Related]
19. [FOLLOW-UP TREATMENT OF CEREBROCRANIAL INJURIES WITH HYDERGINE].
AMANN E; GERSTENBRAND F
Acta Neurochir (Wien); 1964; 11():751. PubMed ID: 14213902
[No Abstract] [Full Text] [Related]
20. [ACTION OF HYDERGINE ON HUMAN EYES AFFECTED BY VARIOUS FORMS OF HYPERTENSION].
DIOTALLEVI M; AURICCHIO G
Ann Ottalmol Clin Ocul; 1964 Jun; 90():322-4. PubMed ID: 14210355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
